☆ 4.6 Editorial Material

Treatment of Heart Failure With Preserved Ejection Fraction Reflections on Its Treatment With an Aldosterone Antagonist

JAMA CARDIOLOGY (2016)

Get Full Text
Add to Collection

Journal

JAMA CARDIOLOGY
Volume 1, Issue 1, Pages 7-8

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamacardio.2015.0356

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Amgen
  2. Celladon
  3. Novartis
  4. Sanofi
  5. AstraZeneca
  6. Bayer
  7. DalCor Pharma UK
  8. Genzyme
  9. Lilly
  10. Medicines Company
  11. MedImmune
  12. Medtronic
  13. Merck
  14. Novo Nordisk
  15. Relypsa
  16. Salix
  17. Sanderling
  18. Takeda
  19. Teva
  20. Thrasos
  21. Vericel
  22. Duke University
  23. Daiichi Sankyo
  24. GlaxoSmithKline
  25. BristolMyers Squibb
  26. Johnson Johnson
  27. Merck (uncompensated)
  28. Theravance
  29. Menarini International
  30. Medscape

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.